MUC1 and idiopathic pulmonary fibrosis: Accordingly, in this study we aimed to determine, for the first time, the potential implication of mucin 1 /KL-6, at the genetic and serological level, as a biomarker of ASSD susceptibility as well as for the differential diagnosis between ASSD-ILD+ and IPF patients.